Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center

Israel Medical Association Journal

Volumn 10, Issue 2, 2008, Pages 109-112

  Amir, Offer ^a   Paz, Hagar ^a   Ammar, Ronny ^a   Yaniv, Nisan ^a   Schliamser, Jorge E ^a   Lewis, Basil S ^a  

^a Department of Anesthesiology Critical Care and Pain Medicine   (Israel)

Author keywords

Chronic heart failure; Natriuretic peptides; Outpatient management; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NATRIURETIC FACTOR; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PATIENT REFERRAL; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; BLOOD; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ISRAEL; METHODOLOGY; MIDDLE AGED; OUTPATIENT DEPARTMENT; PREDICTION AND FORECASTING; SURVIVAL RATE; TIME;

BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; IMMUNOENZYME TECHNIQUES; ISRAEL; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENT CLINICS, HOSPITAL; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SURVIVAL RATE; TIME FACTORS;

EID: 42949130590     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Latour-Perez J, Coves-Orts FJ, Abad-Terrado C, Abraira V, Zamora I. Accuracy of B-type natriuretic peptidel levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail 2006;8:390-9.
2. Glick A, Michowitz Y. Keren G, George J. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy. IMAJ 2006;8:391-5.
3. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75.
4. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriurotic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005;293:1609-16.
5. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
6. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic pepticle and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81.
7. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-12.
8. James SK, Lindahl B, Timmer JR, et al. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy). Am J Cardiol 2006,97:161-72.
9. Bjorklund E, Jernberg T, Johanson P, et al. Admission N-terminal pro-brain natriuretic pepticle and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart 2006:92:735-40.
10. Gardner RS, Chong KS, Morton JJ, McDonagh TA. A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure. Eur J Heart Fail 2007;9:266-71.
11. Hartmann F, Packer M, Coats AJ, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004;110:1780-6.
12. Rothenburger M, Wichter T, Schmid C, et al. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. J Heart Lung Transplant 2004; 23:1189-97.
13. Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin. Eur J Heart Fail 2005;7:557-65.
14. Fried I, Bar-Oz B, Perles Z, Rein AJ, Zonis Z, Nir A. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricule dysfunction. J Pediatr 2006:149:28-31.
15. Cowie MR, Jourdain P, Maisel A, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-18.
16. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416.
17. Battaglia M, Pewsner D, Juni F, Egger M, Bucher HC, Bachmann LM. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure: systematic review of test accuracy studies. Arch Intern Med 2006;166:1073-80.
18. Mueller C, Laule-Kilian K, Schindler C, et al. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med 2006;166:1081-7.
19. Gardner RS, Henderson G, McDonagh TA. Combination of B-type natriuretic pepticle and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. J Heart Lung Transplant 2005;24:303-9.
20. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-43.
21. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-63.
22. Hulsmann M, Berger R, Sturm B, et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J 2002;23: 886-91.